| Adventhealth Care Center Apopka North | |
| 305 East Oak Street, Apopka, Florida 32703 | |
| (407) 880-2266 | |
| Name | Adventhealth Care Center Apopka North |
|---|---|
| Location | 305 East Oak Street, Apopka, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 84.5% |
| Medicare ID (CCN) | 105782 |
| Legal Business Name | Sunbelt Health & Rehab Center Apopka Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1174222194 |
| Organization Name | APOPKA NORTH SNF OPERATIONS LLC |
| Address | 305 E Oak St, Apopka, FL 32703 |
| Phone Number | 407-880-2266 |
News Archive
Perrigo Company plc, a leading global provider of "Quality Affordable Healthcare Products," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for €3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for €2.48 billion and the assumption of €1.1 billion in debt.
Young people with cannabis dependence have altered brain function that may be the source of emotional disturbances and increased psychosis risk that are associated with cannabis abuse, according to a new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
The ongoing meningitis outbreak and its impact on patients and their families is a tragedy, and our hearts go out to the patients and their families who have suffered as a result of these events. The FDA's top priority is to fully contain the health risks associated with the outbreak as quickly as possible, and we will continue to work tirelessly to do so.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.
› Verified 7 days ago
| NPI Number | 1376558189 |
| Organization Name | SUNBELT HEALTH & REHAB CENTER APOPKA INC |
| Doing Business As | ADVENTHEALTH CARE CENTER APOPKA NORTH |
| Address | 305 E Oak St, Apopka, FL 32703 |
| Phone Number | 407-880-2266 |
News Archive
Perrigo Company plc, a leading global provider of "Quality Affordable Healthcare Products," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for €3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for €2.48 billion and the assumption of €1.1 billion in debt.
Young people with cannabis dependence have altered brain function that may be the source of emotional disturbances and increased psychosis risk that are associated with cannabis abuse, according to a new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
The ongoing meningitis outbreak and its impact on patients and their families is a tragedy, and our hearts go out to the patients and their families who have suffered as a result of these events. The FDA's top priority is to fully contain the health risks associated with the outbreak as quickly as possible, and we will continue to work tirelessly to do so.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.
› Verified 7 days ago
| NPI Number | 1730307182 |
| Organization Name | ADVENTIST HEALTH SYSTEM SUNBELT HEALTHCARE CORPORATION |
| Doing Business As | SUNBELT HEALTH CARE & SUB-ACUTE CENTER APOPKA |
| Address | 305 E Oak St, Apopka, FL 32703 |
| Phone Number | 407-880-2266 |
News Archive
Perrigo Company plc, a leading global provider of "Quality Affordable Healthcare Products," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for €3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for €2.48 billion and the assumption of €1.1 billion in debt.
Young people with cannabis dependence have altered brain function that may be the source of emotional disturbances and increased psychosis risk that are associated with cannabis abuse, according to a new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
The ongoing meningitis outbreak and its impact on patients and their families is a tragedy, and our hearts go out to the patients and their families who have suffered as a result of these events. The FDA's top priority is to fully contain the health risks associated with the outbreak as quickly as possible, and we will continue to work tirelessly to do so.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Perrigo Company plc, a leading global provider of "Quality Affordable Healthcare Products," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for €3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for €2.48 billion and the assumption of €1.1 billion in debt.
Young people with cannabis dependence have altered brain function that may be the source of emotional disturbances and increased psychosis risk that are associated with cannabis abuse, according to a new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
The ongoing meningitis outbreak and its impact on patients and their families is a tragedy, and our hearts go out to the patients and their families who have suffered as a result of these events. The FDA's top priority is to fully contain the health risks associated with the outbreak as quickly as possible, and we will continue to work tirelessly to do so.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.6 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.3 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 60.67 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.04 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.93 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.92 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.8 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.72 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.58 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 79.85 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.51 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 33.58 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.44 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.43 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.95 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 72.2 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 78.78 | 82.93 |
News Archive
Perrigo Company plc, a leading global provider of "Quality Affordable Healthcare Products," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for €3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for €2.48 billion and the assumption of €1.1 billion in debt.
Young people with cannabis dependence have altered brain function that may be the source of emotional disturbances and increased psychosis risk that are associated with cannabis abuse, according to a new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
The ongoing meningitis outbreak and its impact on patients and their families is a tragedy, and our hearts go out to the patients and their families who have suffered as a result of these events. The FDA's top priority is to fully contain the health risks associated with the outbreak as quickly as possible, and we will continue to work tirelessly to do so.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.
› Verified 7 days ago
Adventhealth Care Center Apopka South Location: 3355 E Semoran Blvd, Apopka, Florida 32703 Phone: (407) 862-6263 | |
Adventhealth Care Center Apopka North Location: 305 East Oak Street, Apopka, Florida 32703 Phone: (407) 880-2266 | |
Apopka Health And Rehabilitation Center Location: 2001 Alston Bay Blvd, Apopka, Florida 32703 Phone: (407) 565-5990 |